A 2009 report details a U.S.-funded HIV vaccine trial in Thailand that showed a "modest" 31.2% efficacy. Dr. Fauci appears on Bloomberg to discuss the results, which the hosts interpret as a move to attract pharmaceutical investment and early groundwork for mRNA technology.